TEZOSENTAN

TEZOSENTAN Struktur
180384-57-0
CAS-Nr.
180384-57-0
Englisch Name:
TEZOSENTAN
Synonyma:
RO 610612;TEZOSENTAN;N-(2-(2-(2H-Tetrazol-5-yl)pyridin-4-yl)-6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)pyrimidin-4-yl;N-(2-(2-(2H-Tetrazol-5-yl)pyridin-4-yl)-6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)pyrimidin-4-yl)-5;N-(2-(2-(2H-Tetrazol-5-yl)pyridin-4-yl)-6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)pyrimidin-4-yl)-5-isopropylpyridine-2-sulfonamide;N-[6-(2-Hydroxyethoxy)-5-(2-Methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)-4-pyridinyl]-4-pyriMidinyl]-5-(1-Methylethyl)-2-pyridinesulfonaMide;2-Pyridinesulfonamide, N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)-4-pyridinyl]-4-pyrimidinyl]-5-(1-methylethyl)-
CBNumber:
CB6790143
Summenformel:
C27H27N9O6S
Molgewicht:
605.62
MOL-Datei:
180384-57-0.mol

TEZOSENTAN Eigenschaften

Schmelzpunkt:
198-200°
Siedepunkt:
761.2±70.0 °C(Predicted)
Dichte
1.432±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
Löslichkeit
Soluble in DMSO
pka
2.93±0.10(Predicted)
Aggregatzustand
Solid
Farbe
Off-white to gray

Sicherheit

TEZOSENTAN Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

A potent dual endothelian (ETA/ETB) receptor antagonist optimized from Bosentan (B675900). Tezosentan is used in the treatment of congestive heart failure.

TEZOSENTAN Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


TEZOSENTAN Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 32)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Wuhan Topule Biopharmaceutical Co., Ltd
+8618327326525
masar@topule.com China 8474 58
J & K SCIENTIFIC LTD. 010-82848833 400-666-7788
jkinfo@jkchemical.com China 96815 76
Chemsky (shanghai) International Co.,Ltd 021-50135380
shchemsky@sina.com China 15421 60
BOC Sciences 1-631-485-4226; 16314854226
info@bocsci.com United States 14059 65
Beijing HuaMeiHuLiBiological Chemical 010-56205725
waley188@sohu.com China 12338 58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. 025-66113011 18112977050
cb6@aikonchem.com China 16687 50
SPIRO PHARMA
eric_feng1954@126.com China 9254 55
BOC Sciences 16314854226
info@bocsci.com United States 9926 65
Shanghai Han-Xiang Chemical Co., Ltd. 15971444841
amber@biochempartner.com China 3063 58

180384-57-0()Verwandte Suche:


  • TEZOSENTAN
  • N-[6-(2-Hydroxyethoxy)-5-(2-Methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)-4-pyridinyl]-4-pyriMidinyl]-5-(1-Methylethyl)-2-pyridinesulfonaMide
  • N-(2-(2-(2H-Tetrazol-5-yl)pyridin-4-yl)-6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)pyrimidin-4-yl)-5
  • N-(2-(2-(2H-Tetrazol-5-yl)pyridin-4-yl)-6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)pyrimidin-4-yl
  • N-(2-(2-(2H-Tetrazol-5-yl)pyridin-4-yl)-6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)pyrimidin-4-yl)-5-isopropylpyridine-2-sulfonamide
  • RO 610612
  • 2-Pyridinesulfonamide, N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)-4-pyridinyl]-4-pyrimidinyl]-5-(1-methylethyl)-
  • 180384-57-0
  • C27H27N9O6S
  • Aromatics
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Sulfur & Selenium Compounds
Copyright 2019 © ChemicalBook. All rights reserved